Table 1 Summary of Myostatin (Mstn) immunopositivity within the different areas of the vessel wall in the different stages of plaque progression.
Lesion Type6 | MEDIA (VSMCs) | NEOVESSELS | INTIMA/NEOINTIMA | LESION/FIBROTIC CAP | INFILTRATING CELLS | Total case number | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Posit. | N | Posit. | N | Posit. | N | Posit. | N | Posit. | N | ||
Norm | 0 | 6 | na | 0 | 8 | na | na | N = 8 | |||
+/− | 2 | ||||||||||
AIT | +/− | 10 | na | 0 | 12 | na | na | N = 12 | |||
+ | 2 | ||||||||||
IX | 3 | na | 0 | 11 | na | 0 | 12 | N = 12 | |||
+/++ | 9 | + | 1 | ||||||||
PIT | 0 | 2 | 0 | 9 | 0 | 10 | na | 0 | 10 | N = 10 | |
+/++ | 7 | ++ | 1 | ||||||||
++ | 1 | ||||||||||
EFA | 0 | 1 | 0 | 9 | 0 | 9 | 0 | 9 | 0 | 9 | N = 9 |
+/++ | 8 | ||||||||||
LFA | +/++ | 3 | 0 | 3 | 0 | 1 | 0 | 3 | 0 | 3 | N = 5 |
++ | 2 | ++ | 2 | ++ | 4 | ++ | 2 | + | 2 | ||
TCFA | 0 | 1 | 0 | 5 | 0 | 1 | 0 | 4 | 0 | 5 | N = 8 |
+/++ | 4 | ++ | 3 | +/++ | 7 | +/++ | 4 | + | 2 | ||
++ | 3 | ++ | 1 | ||||||||
PR | 0 | 1 | 0 | 1 | 0 | 10 | 0 | 10 | 0 | 1 | N = 10 |
+ | 9 | + + | 9 | ++ | 9 | ||||||
HR | + | 11 | 0 | 9 | 0 | 8 | 0 | 5 | 0 | 9 | N = 11 |
+++ | 2 | + | 3 | +/++ | 6 | + | 2 | ||||
FCP | +/++ | 12 | 0 | 6 | 0 | 5 | 0 | 7 | 0 | 6 | N = 12 |
+ | 6 | + | 7 | +/++ | 5 | + | 6 |